Solid Biosciences Inc. - Common Stock, $0.001 par value per share (SLDB)

Historical Holders from Q1 2018 to Q3 2025

Symbol
SLDB on Nasdaq
CUSIP
83422E105
Type / Class
Equity / Common Stock, $0.001 par value per share
Shares outstanding
79.2M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
12.2K
Holdings value
$75.5K
% of all portfolios
0%
Grand Portfolio weight change
+0%
Number of holders
4
Number of buys
1
Average Value change %
+0%
Average buys %
+0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Solid Biosciences Inc. - Common Stock, $0.001 par value per share (SLDB)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
RA CAPITAL MANAGEMENT, L.P. 9.9% $3.6M 7.99M RA Capital Management, L.P. Feb 19, 2025
BCLS SB Investco, LP 7.8% $238K 6.18M BCLS II Investco, LP Feb 19, 2025

Institutional Holders of Solid Biosciences Inc. - Common Stock, $0.001 par value per share (SLDB)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 12.2K $75.5K +$70.9K $6.17 4
2025 Q2 733 $3.57K +$1.35K $4.87 3
2025 Q1 478 $1.77K +$1.74K $3.71 3
2024 Q4 7 $28.00 $4.00 1
2024 Q3 7 $49.00 $0 $7.00 1
2024 Q2 7 $40.00 +$6.00 $5.71 1
2024 Q1 6 $80.00 $0 $13.33 1
2023 Q4 6 $37.00 $0 $6.17 1
2023 Q3 6 $15.00 -$346 $2.50 1
2023 Q2 72 $377 $0 $5.20 2
2023 Q1 72 $341 -$57.8K $4.70 2
2022 Q4 10.8K $58.1K -$29.1M $5.36 2
2022 Q3 62.9M $29.2M +$794K $0.47 52
2022 Q2 64.2M $39.5M -$5.53M $0.62 56
2022 Q1 69.3M $83.2M -$8.05M $1.20 73
2021 Q4 75.5M $132M -$5.13M $1.75 78
2021 Q3 77M $184M -$8.37M $2.39 86
2021 Q2 80M $293M +$60.7K $3.66 86
2021 Q1 79.1M $438M +$134M $5.53 105
2020 Q4 54.6M $414M +$230M $7.58 76
2020 Q3 25.4M $51.6M -$3.13M $2.03 55
2020 Q2 26.7M $78.3M +$21.2M $2.93 65
2020 Q1 19.6M $46.9M -$1.35M $2.39 70
2019 Q4 19.9M $88.5M -$123M $4.45 68
2019 Q3 32.1M $332M +$96M $10.34 69
2019 Q2 18.6M $107M +$20.1M $5.75 71
2019 Q1 17.1M $157M -$213M $9.20 75
2018 Q4 24.2M $648M +$128M $26.80 76
2018 Q3 18.6M $878M +$64.7M $47.18 76
2018 Q2 15.3M $545M +$93.3M $35.63 63
2018 Q1 15.6M $117M +$117M $7.50 55